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iral Myocarditis
s Infection of the Heart Required?*
irk U. Knowlton, MD, Byung-Kwan Lim, PHD
a Jolla, California
oxsackieviral myocarditis continues to be a disease that is
ifficult to diagnose and treat in spite of decades of research
n both patients and mice. The prominence of the inflam-
atory response combined with the challenge in definitively
dentifying viral infection within the myocardium in a given
atient has stimulated a question regarding the role of virus
nfection of the cardiac myocyte versus activation of a
umoral and cellular autoimmune process that is indepen-
ent of infection of the cardiac myocyte. Is it possible that
rimary infection of other organs or nonmyocytes within the
eart (1) is sufficient to activate an autoimmune phenome-
on directed against myocardial cells and myocardial pro-
eins without direct infection of the cardiac myocyte?
See page 1219
There are a number of lines of evidence that suggest the
mportance of an autoimmune phenomenon (2,3) in both
atients with myocarditis and mice infected with the Cox-
ackievirus (2,4–7). In contrast, there are considerable data
emonstrating that enteroviruses can be detected within the
yocardium of patients with acute onset of myocarditis and in
ice infected with Coxsackievirus. Virus infection has also
een associated with a direct myocytopathic effect (8–10).
ltogether, the evidence suggests that both the direct effects of
yocardial infection and the activation of the immune process
ither in an autoimmune or antiviral manner are likely to have
ignificant roles in the development of myocarditis. However,
t has not been clearly demonstrated whether infection of the
yocardium is required for activation of the viral myocarditis
henotype.
Elucidation of the mechanisms by which virus infection
an affect the host organism has been greatly facilitated by
dentification of the Coxsackievirus-adenovirus receptor
CAR). In addition to its role as a virus receptor, CAR is a
ransmembrane immunoglobulin domain-containing adhe-
ion molecule that belongs to the family of adhesion
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merican College of Cardiology.t
From the Department of Medicine, University of California San Diego, Division
f Cardiology, La Jolla, California.olecules such as vascular cell adhesion molecule (VCAM)
nd intercellular adhesion molecule (ICAM). CAR has
een shown to be expressed at relatively high levels on
yocardial cells, but it is also expressed in other organs such
s the liver, pancreas, and brain (11–13). In the adult
yocardium, CAR is primarily localized in the intercalated
isc and the cell–cell junctions of the atrioventricular (AV)
ode. Recently, CAR expression has been shown to be
equired for normal embryonic development, and when
isrupted only in the heart, electrical conduction between
he atria and ventricles is interrupted, leading to complete
eart block and loss of connexin-45 in the AV node (14,15).
In cultured cells, infection by most Coxsackieviruses requires
xpression of CAR. However, less is known about whether
AR is required for infection of cells in the intact animal or in
he intact heart. The importance of a potential alternative
echanism of viral infection has been demonstrated with
denovirus where infection of cultured cells has been shown to
e mediated by the expression of CAR (11,13). However,
fficient hepatocyte infection can occur through a CAR-
ndependent manner in vivo that is dependent on Factor X of
he coagulation cascade (16).
In this issue of the Journal, Shi et al. (17) report a series of
xperiments that demonstrate important points in relation to
he pathogenesis of Coxsackieviral myocarditis. The first is that
AR is required for infection of myocardial cells in vivo, and
he second is that infection of myocardial cells is required to
nduce myocarditis in the Coxsackievirus-infected mouse. To
emonstrate these points, the authors generated a mouse in
hich the first exon of CAR was flanked by lox-p sequences
hat allow recombination and deletion of intervening deoxyri-
onucleic acid in the presence of the bacteriophage-derived
RE recombinase. Because the authors had previously dem-
nstrated that in their model cardiac-specific deletion of CAR
uring development led to embryonic lethality (15), they used
somewhat more sophisticated strategy that allowed for
eletion of CAR in the adult heart. This was accomplished by
xpressing a modified CRE under the direction of the cardiac-
pecific, -myosin heavy chain promoter. The modified CRE
ontains a mutated estrogen receptor on each side of the CRE
ecombinase. This mutated CRE is maintained in the cyto-
lasm until it binds to tamoxifen, at which point it translo-
ates from the cytoplasm to the nucleus, stimulating recom-
ination of the genome at the lox-p sites. In the current case
his deletes the first exon of CAR, preventing expression of
AR. Because the modified CRE is expressed only in the
ardiac myocytes, the deletion occurs only in the myocardial
ells. This strategy leads to reduction of CAR expression in
he myocardium by 90% at 3 months after administration of
amoxifen. At this point the mice were infected with
oxsackievirus B3 (CVB3), and their hearts were analyzed
t days 10 and 28 after infection.
Key results from these experiments included the findingshat the mice that lacked CAR in the cardiac myocytes had
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Viral Myocarditis April 7, 2009:1227–8o significant viral infection or cellular inflammation in the
eart. In addition, ventricular function was not significantly
ffected by viral infection of the mouse. This demonstrated
hat CAR expression is required for viral infection of the
ardiac myocytes in vivo and that the myocarditis does not
ccur in the absence of infection of the cardiac myocyte.
econdary findings include a marked decrease in the mes-
enger ribonucleic acid levels for the cytokines interleukin-6,
nterleukin-10, and tumor necrosis factor- in infected
AR knockout mice compared with infected wild-type
ice. However, tumor necrosis factor- messenger ribonu-
leic acid levels were still somewhat elevated in the infected
AR knockout mice compared with uninfected mice. An-
ther finding was that the level of CVB3 infection of
ifferent tissues did not correlate with the level of CAR
xpression in the wild-type mouse but that all tissues that
ere infected expressed CAR. There are a number of
echanisms by which viral infection might be inhibited in
ertain tissues. For example, replication of CVB3 in the
iver is markedly increased in the absence of type I interferon
ignaling (18), thus demonstrating the importance of the
nnate immune function within the cell in determining a
issue’s susceptibility to viral infection.
Although the conclusions from the current article are
uite clear in that viral infection of the heart was completely
nhibited in the absence of CAR, there are some caveats that
hould be kept in mind. To be certain that the differences in
nfectivity and myocardial inflammation are only secondary
o knockout of CAR rather than difference in mouse strain
ackground, it is generally most suitable to perform the
nalysis in an inbred strain of mice. The experiments
erformed in the study by Shi et al. (17) used outbred mice
hat were derived from crosses of 129SVJ and C57black6.
owever, to control for infectivity between the groups, the
uthors analyzed the level of infection in noncardiac tissues and
ound that infection of the pancreas and spleen was not
ifferent between the mice that lacked CAR in the heart
ompared with infected wild-type mice. It is also notable, that
he immune response within a mouse after CVB3 infection is
t least partially dependent on the strain of mice analyzed
19,20). This outcross might not be representative of all mouse
odels of CVB3 infection. Finally, one cannot exclude the
ossibility that there is activation of some form of autoimmune
rocess that might occur at later stages after infection.
In summary, Shi et al. (17) have demonstrated that CAR
s required for Coxsackievirus infection of the cardiac
yocyte and that in the absence of infection of the heart,
here is no significant evidence of myocarditis after CVB3
nfection in spite of evidence of infection of other tissues.
hese findings demonstrate the importance of the interac-
ion of the virus with the cardiac myocyte in the initiation of
iral myocarditis. Strategies that can interfere with these
nteractions will likely affect the severity of viral myocarditis
fter Coxsackieviral infection.
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